These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2026500)

  • 41. A clinical comparison of 99mTc-DPD and two 99mTc-MDP agents.
    Vorne M; Vähätalo S; Lantto T
    Eur J Nucl Med; 1983; 8(9):395-7. PubMed ID: 6226527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The biological distributions of some technetium-MDP components isolated by anion exchange high performance liquid chromatography.
    Tanabe S; Zodda JP; Libson K; Deutsch E; Heineman WR
    Int J Appl Radiat Isot; 1983 Dec; 34(12):1585-92. PubMed ID: 6230323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals.
    Garnuszek P; Pawlak D; Licińska I; Kamińska A
    Appl Radiat Isot; 2003 Apr; 58(4):481-8. PubMed ID: 12672628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
    Buell U; Kirsch CM; Kleinhans E; Jäger B
    J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
    [No Abstract]   [Full Text] [Related]  

  • 47. Nuclear medicine studies in evaluation of skeletal lesions in children with histiocytosis X.
    Siddiqui AR; Tashjian JH; Lazarus K; Wellman HN; Baehner RL
    Radiology; 1981 Sep; 140(3):787-9. PubMed ID: 6456475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study.
    Ozdogan O; Ertay T; Arslan G; Sisman AR; Capa Kaya G; Yilmaz O; Coker C; Gure A; Durak H
    Ann Nucl Med; 2008 Jun; 22(5):357-62. PubMed ID: 18600412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initial Tc-99m diphosphonate uptake in mineralized and demineralized bone implants in rats.
    Lysell L; Rohlin M
    Int J Oral Surg; 1985 Aug; 14(4):371-5. PubMed ID: 3928513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM; Moore AE; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP].
    Hu S; Deng H; Jiang S; Luo S; Lei Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Sohaib M; Ahmad M; Jehangir M; Perveen A
    Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
    Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
    Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
    Molloi S; Mazess R; Bendsen H; Wilson M
    Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 99mTc(V)-DMSA and 99mTc-MDP uptake and no 67Ga-citrate uptake in a case of primary pulmonary leiomyosarcoma.
    Ohta H; Komibuchi T; Nishiyama H; Shizuki K; Miyaki Y
    Ann Nucl Med; 1992 Aug; 6(3):191-3. PubMed ID: 1327043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [99m-Tc alendronate as a new option in bone gammagraphy].
    Montoya-Molina CE; Sepúlveda-Méndez J; Arteaga-de-Murphy C; Meléndez-Alafort L; Rojas-Bautista JC; López-Alvarenga JC
    Rev Invest Clin; 1997; 49(5):373-7. PubMed ID: 9527697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
    Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
    J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 99mTc-MDP uptake and histological changes during rat bone marrow regeneration.
    Chisin R; Gazit D; Ulmansky M; Laron A; Atlan H; Sela J
    Int J Rad Appl Instrum B; 1988; 15(4):469-76. PubMed ID: 3255743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.